Loading clinical trials...
Loading clinical trials...
Current options to treat insulin resistance in diabetes are fairly limited. For this reason, novel treatments would represent a major progress. The generic drug hydroxychloroquine (HCQ) has poorly und...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Pittsburgh
NCT07415720 · Diabete Type 2, Obesity & Overweight, and more
NCT05543083 · Insulin Resistance, Depression, and more
NCT07403604 · Hyperinsulinemia, Insulin Resistance, and more
NCT07286747 · Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
NCT00001987 · Diabetes Mellitus, Severe Insulin Resistance
UPMC Montefiore Hospital
Pittsburgh, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions